These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26738673)

  • 1. Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.
    Zhou L; Zhang J; Jiang XM; Xie DJ; Wang JS; Li L; Li B; Wang ZM; Rothman AMK; Lawrie A; Chen SL
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2013-2023. PubMed ID: 26738673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
    Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
    BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic innervation of canine pulmonary artery and morphometric and functional analysis in dehydromonocrotaline-induced models after pulmonary artery denervation.
    Jiang X; Zhang J; Zhou L; Luo J; Wang J; Li L; Chen S
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):708-717. PubMed ID: 33057705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
    Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
    J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Denervation: Update on Clinical Studies.
    Zhang H; Chen SL
    Curr Cardiol Rep; 2019 Sep; 21(10):124. PubMed ID: 31486924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
    Zhang H; Zhang J; Chen M; Xie DJ; Kan J; Yu W; Li XB; Xu T; Gu Y; Dong J; Gu H; Han Y; Chen SL
    JACC Cardiovasc Interv; 2019 Feb; 12(3):274-284. PubMed ID: 30732732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.
    Chen SL; Zhang YJ; Zhou L; Xie DJ; Zhang FF; Jia HB; Wong SS; Kwan TW
    EuroIntervention; 2013 Jun; 9(2):269-76. PubMed ID: 23466961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.
    Chen SL; Zhang H; Xie DJ; Zhang J; Zhou L; Rothman AM; Stone GW
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002837. PubMed ID: 26553699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter radiofrequency pulmonary artery denervation in swine: the evaluation of lesion degree, hemodynamics and pulmonary hypertension inducibility.
    Goncharova NS; Condori Leandro HI; Vakhrushev AD; Koshevaya EG; Skorik YA; Mitrofanova LB; Murashova LA; Korobchenko LE; Andreeva EM; Lebedev DS; Moiseeva OM; Mikhaylov EN
    BMC Pulm Med; 2021 Dec; 21(1):418. PubMed ID: 34922518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
    Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
    Huang Y; Liu YW; Pan HZ; Zhang XL; Li J; Xiang L; Meng J; Wang PH; Yang J; Jing ZC; Zhang H
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):704-718. PubMed ID: 30816802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beneficial effects of renal denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension].
    Zhang S; Zhao Q; Jiang X; Yang B; Dai Z; Wang X; Wang X; Guo Z; Yu S; Tang Y; Hu W; Huang C
    Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(14):1108-12. PubMed ID: 26081215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
    Zhang H; Wei Y; Zhang C; Yang Z; Kan J; Gu H; Fan F; Gu H; Wang Q; Xie D; Zhang G; Guo X; Yin Y; Jin B; Zhou H; Yang Z; Wang Z; Xin Y; Zhang C; Meng L; Wang X; Sun J; Zhao C; Zhang J; Yan X; Chen F; Yao C; Stone GW; Chen SL
    JACC Cardiovasc Interv; 2022 Dec; 15(23):2412-2423. PubMed ID: 36121246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
    Zhang J; Kan J; Wei Y; Zhang C; Yang Z; Gu H; Fan F; Gu H; Wang Q; Xie D; Zhang G; Guo X; Yin Y; Jin B; Zhou H; Yang Z; Wang Z; Xin Y; Zhang C; Meng L; Wang X; Zhao C; Zhang H; Yan X; Chen F; Yao C; Benza RL; Stone GW; Chen SL
    J Heart Lung Transplant; 2023 Aug; 42(8):1140-1151. PubMed ID: 36990173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progress of pulmonary artery denervation.
    Xie Y; Liu N; Xiao Z; Yang F; Zeng Y; Yang Z; Xia Y; Chen Z; Xiao Y
    Cardiol J; 2022; 29(3):381-387. PubMed ID: 33438182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.
    Garcia-Lunar I; Pereda D; Santiago E; Solanes N; Nuche J; Ascaso M; Bobí J; Sierra F; Dantas AP; Galán C; San Antonio R; Sánchez-Quintana D; Sánchez-González J; Barberá JA; Rigol M; Fuster V; Ibáñez B; Sabaté M; García-Álvarez A
    Basic Res Cardiol; 2019 Jan; 114(2):5. PubMed ID: 30635778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary Vascular Remodeling Characteristics of Pulmonary Arterial Hypertension Mouse Model Induced by Left Pneumonectomy and Jugular Vein Injection of Monocrotaline Pyrrole].
    Gu L; Liu CJ; Xie L; Gu L; Yu L; Liu HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):821-827. PubMed ID: 36224684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.